BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30002128)

  • 1. Molecular analysis of enthesopathy in a mouse model of hypophosphatemic rickets.
    Liu ES; Martins JS; Zhang W; Demay MB
    Development; 2018 Aug; 145(15):. PubMed ID: 30002128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired 1,25-dihydroxyvitamin D3 action underlies enthesopathy development in the Hyp mouse model of X-linked hypophosphatemia.
    Rana R; Baker JT; Sorsby M; Jagga S; Venkat S; Almardini S; Liu ES
    JCI Insight; 2023 Sep; 8(17):. PubMed ID: 37490334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineral tessellation in mouse enthesis fibrocartilage, Achilles tendon, and Hyp calcifying enthesopathy: A shared 3D mineralization pattern.
    Buss DJ; Rechav K; Reznikov N; McKee MD
    Bone; 2023 Sep; 174():116818. PubMed ID: 37295663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets.
    Wöhrle S; Henninger C; Bonny O; Thuery A; Beluch N; Hynes NE; Guagnano V; Sellers WR; Hofmann F; Kneissel M; Graus Porta D
    J Bone Miner Res; 2013 Apr; 28(4):899-911. PubMed ID: 23129509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice.
    Liang G; Katz LD; Insogna KL; Carpenter TO; Macica CM
    Calcif Tissue Int; 2009 Sep; 85(3):235-46. PubMed ID: 19609735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Enthesopathy of XLH Is a Mechanical Adaptation to Osteomalacia: Biomechanical Evidence from Hyp Mice.
    Macica CM; Luo J; Tommasini SM
    Calcif Tissue Int; 2022 Sep; 111(3):313-322. PubMed ID: 35618776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
    Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eldecalcitol Causes FGF23 Resistance for Pi Reabsorption and Improves Rachitic Bone Phenotypes in the Male Hyp Mouse.
    Kaneko I; Segawa H; Ikuta K; Hanazaki A; Fujii T; Tatsumi S; Kido S; Hasegawa T; Amizuka N; Saito H; Miyamoto KI
    Endocrinology; 2018 Jul; 159(7):2741-2758. PubMed ID: 29878089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets/osteomalacia.
    Aono Y; Yamazaki Y; Yasutake J; Kawata T; Hasegawa H; Urakawa I; Fujita T; Wada M; Yamashita T; Fukumoto S; Shimada T
    J Bone Miner Res; 2009 Nov; 24(11):1879-88. PubMed ID: 19419316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,25-Dihydroxyvitamin D Alone Improves Skeletal Growth, Microarchitecture, and Strength in a Murine Model of XLH, Despite Enhanced FGF23 Expression.
    Liu ES; Martins JS; Raimann A; Chae BT; Brooks DJ; Jorgetti V; Bouxsein ML; Demay MB
    J Bone Miner Res; 2016 May; 31(5):929-39. PubMed ID: 26751835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-FGF-23 neutralizing antibodies ameliorate muscle weakness and decreased spontaneous movement of Hyp mice.
    Aono Y; Hasegawa H; Yamazaki Y; Shimada T; Fujita T; Yamashita T; Fukumoto S
    J Bone Miner Res; 2011 Apr; 26(4):803-10. PubMed ID: 20939065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF23 suppresses chondrocyte proliferation in the presence of soluble α-Klotho both in vitro and in vivo.
    Kawai M; Kinoshita S; Kimoto A; Hasegawa Y; Miyagawa K; Yamazaki M; Ohata Y; Ozono K; Michigami T
    J Biol Chem; 2013 Jan; 288(4):2414-27. PubMed ID: 23235154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of migrating tendon-bone attachments involves replacement of progenitor populations.
    Felsenthal N; Rubin S; Stern T; Krief S; Pal D; Pryce BA; Schweitzer R; Zelzer E
    Development; 2018 Dec; 145(24):. PubMed ID: 30504126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Musculoskeletal Comorbidities and Quality of Life in ENPP1-Deficient Adults and the Response of Enthesopathy to Enzyme Replacement Therapy in Murine Models.
    Ferreira CR; Ansh AJ; Nester C; O'Brien C; Stabach PR; Murtada SI; Lester ER; Khursigara G; Molloy L; Carpenter TO; Braddock DT
    J Bone Miner Res; 2022 Mar; 37(3):494-504. PubMed ID: 34882836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Effects of FGF23 c-tail Fc in a Murine Preclinical Model of X-Linked Hypophosphatemia Via the Selective Modulation of Phosphate Reabsorption.
    Johnson K; Levine K; Sergi J; Chamoun J; Roach R; Vekich J; Favis M; Horn M; Cao X; Miller B; Snyder W; Aivazian D; Reagan W; Berryman E; Colangelo J; Markiewicz V; Bagi CM; Brown TP; Coyle A; Mohammadi M; Magram J
    J Bone Miner Res; 2017 Oct; 32(10):2062-2073. PubMed ID: 28600887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Scx+/Sox9+ cells as potential progenitor cells for postnatal supraspinatus enthesis formation and healing after injury in mice.
    Ideo K; Tokunaga T; Shukunami C; Takimoto A; Yoshimoto Y; Yonemitsu R; Karasugi T; Mizuta H; Hiraki Y; Miyamoto T
    PLoS One; 2020; 15(12):e0242286. PubMed ID: 33259516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of calcimimetic R568 and calcitriol in mineral homeostasis in the Hyp mouse, a murine homolog of X-linked hypophosphatemia.
    Leifheit-Nestler M; Kucka J; Yoshizawa E; Behets G; D'Haese P; Bergen C; Meier M; Fischer DC; Haffner D
    Bone; 2017 Oct; 103():224-232. PubMed ID: 28728941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Circulating FGF23 Does Not Lead to Cardiac Hypertrophy in the Male Hyp Mouse Model of XLH.
    Liu ES; Thoonen R; Petit E; Yu B; Buys ES; Scherrer-Crosbie M; Demay MB
    Endocrinology; 2018 May; 159(5):2165-2172. PubMed ID: 29635291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF signaling patterns cell fate at the interface between tendon and bone.
    Roberts RR; Bobzin L; Teng CS; Pal D; Tuzon CT; Schweitzer R; Merrill AE
    Development; 2019 Aug; 146(15):. PubMed ID: 31320326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel Phex mutation in a new mouse model of hypophosphatemic rickets.
    Owen C; Chen F; Flenniken AM; Osborne LR; Ichikawa S; Adamson SL; Rossant J; Aubin JE
    J Cell Biochem; 2012 Jul; 113(7):2432-41. PubMed ID: 22573557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.